Literature DB >> 1612320

Abnormal REM sleep in the irritable bowel syndrome.

D Kumar1, P D Thompson, D L Wingate, C K Vesselinova-Jenkins, G Libby.   

Abstract

Motor abnormalities of the small bowel that occur only during the waking state have been reported in the irritable bowel syndrome (IBS), suggesting that central nervous system arousal is a necessary condition for expression of the disorder and that it may reflect inappropriate brain-gut interaction. This possible relationship was explored further by synchronous polysomnography and recording of upper small bowel motility in six healthy subjects and six patients with IBS. During sleep, there was no difference in the patterns of intestinal motility between the two groups. There was no difference between the rapid eye movement (REM) latency or number of REM episodes, but the proportion of REM sleep was markedly increased (36.5% +/- 5.7% vs. 18.2% +/- 5.7%; P less than 0.01) in the IBS group, although the duration of sleep was similar (468 +/- 13 minutes in IBS vs. 444 +/- 10 minutes in controls; P greater than 0.1). Sleep apnea was detected in three of six patients with IBS but was not seen in controls. The data are consistent with the model of IBS as a disorder of brain-gut interaction.

Entities:  

Mesh:

Year:  1992        PMID: 1612320     DOI: 10.1016/0016-5085(92)91089-m

Source DB:  PubMed          Journal:  Gastroenterology        ISSN: 0016-5085            Impact factor:   22.682


  22 in total

1.  Melatonin: a novel treatment for IBS?

Authors:  S Elsenbruch
Journal:  Gut       Date:  2005-10       Impact factor: 23.059

2.  Impaired sleep quality in Crohn's disease depends on disease activity.

Authors:  Rachel Gingold-Belfer; Nir Peled; Sigal Levy; Neriel Katz; Yaron Niv; Ronnie Fass; Gerald Fraser; Ram Dickman
Journal:  Dig Dis Sci       Date:  2013-10-11       Impact factor: 3.199

3.  Does Fibre-fix provided to people with irritable bowel syndrome who are consuming a low FODMAP diet improve their gut health, gut microbiome, sleep and mental health? A double-blinded, randomised controlled trial.

Authors:  Ran Yan; Mandy Murphy; Angela Genoni; Evania Marlow; Ian C Dunican; Johnny Lo; Lesley Andrew; Amanda Devine; Claus T Christophersen
Journal:  BMJ Open Gastroenterol       Date:  2020-08

4.  Sleep and gastric function in irritable bowel syndrome: derailing the brain-gut axis.

Authors:  W C Orr; M D Crowell; B Lin; M J Harnish; J D Chen
Journal:  Gut       Date:  1997-09       Impact factor: 23.059

5.  Prevalence of restless legs syndrome in patients with irritable bowel syndrome.

Authors:  P Patrick Basu; N James Shah; Nithya Krishnaswamy; Tommy Pacana
Journal:  World J Gastroenterol       Date:  2011-10-21       Impact factor: 5.742

6.  An association between poor sleep quality and the severity of IBS symptoms.

Authors:  D Wingate
Journal:  Dig Dis Sci       Date:  1994-11       Impact factor: 3.199

7.  Sleep Disturbances Can Be Prospectively Observed in Patients with an Inactive Inflammatory Bowel Disease.

Authors:  Ariella Bar-Gil Shitrit; Chen Chen-Shuali; Tomer Adar; Benjamin Koslowsky; Shimon Shteingart; Kalman Paz; Sorina Grisaru-Granovsky; Eran Goldin; Gali Epstein Shochet; David Shitrit
Journal:  Dig Dis Sci       Date:  2018-07-19       Impact factor: 3.199

8.  Sleep disturbance influences gastrointestinal symptoms in women with irritable bowel syndrome.

Authors:  M Jarrett; M Heitkemper; K C Cain; R L Burr; V Hertig
Journal:  Dig Dis Sci       Date:  2000-05       Impact factor: 3.199

9.  Sleep disturbances are linked to both upper and lower gastrointestinal symptoms in the general population.

Authors:  F Cremonini; M Camilleri; A R Zinsmeister; L M Herrick; T Beebe; N J Talley
Journal:  Neurogastroenterol Motil       Date:  2008-09-18       Impact factor: 3.598

10.  Impact of corticotropin-releasing hormone on gastrointestinal motility and adrenocorticotropic hormone in normal controls and patients with irritable bowel syndrome.

Authors:  S Fukudo; T Nomura; M Hongo
Journal:  Gut       Date:  1998-06       Impact factor: 23.059

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.